LINDA RUPPERT: Open Payments
NPI 1477542330 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 12 payments from 8 companies in 2025. Trend: 2023 $368 · 2024 $273 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Anumana, Inc. | 1 | $116 |
| Novartis Pharmaceuticals Corporation | 5 | $75 |
| Novo Nordisk Inc | 1 | $35 |
| PFIZER INC. | 1 | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: ECG-AI LEF, LEQVIO, Ozempic, VYNDAQEL, LifeVest, ONPATTRO, Kerendia, ELIQUIS.
Industry payments across PA — which companies pay providers there.
